The Cancer Research Institute (CRI) Clinic and Laboratory Integration Program (CLIP) supports research bridging laboratory discovery and clinical application in cancer immunology. The program promotes translational studies that connect basic science insights with patient-centered therapeutic strategies to accelerate clinical impact.
Eligibility criteria:
-
Applicants must hold a faculty appointment (assistant professor or higher) by the award start date.
-
Research must be conducted at a nonprofit medical school or research center in the U.S. or abroad.
-
Only tenure-track or equivalent positions are eligible; adjunct/acting faculty are not.
-
CRI does not fund for-profit institutions.
-
LOI required before full application invitation.
Funding details:
-
Award: 300,000 USD over 2 years (150,000 USD per year).
-
Eligible for renewal with an additional 2-year, 300,000 USD extension based on performance.
-
Indirect costs: up to 10% (in addition to the total award).
-
Funds support research directly informing clinical practice, including preclinical modeling, biomarker discovery, resistance mechanisms, and therapeutic innovation.
-
Co-funding available for chordoma-focused studies in collaboration with the Chordoma Foundation.
Deadline:
-
Letter of Intent: December 1, 2025.
-
Full proposal (by invitation): March 2, 2026.
-
Award activation: July 1, 2026.
Where to go for further information:
- For questions: [email protected]
- Program information available at cancerresearch.org.